CannaTech

SEPTEMBER 23, 2019

NICE develop evidence-based guidelines on a wide range of health-related topics, including integrating novel and emerging therapies. Last week NICE released the first draft of their evidence-based guidelines, concluding it could not recommend CBMPs for routine use because of high cost and a dearth of clinical trial evidence.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

NOVEMBER 15, 2021

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. About Virpax Pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

DECEMBER 8, 2021

.–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. This data should strengthen the Company’s IND filing in advance of the anticipated start of first-in-human clinical trials. About Virpax Pharmaceuticals. Mack, Chairman and CEO of Virpax. Forward-Looking Statement.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Cannabis Law Report

JULY 29, 2021

CB4 products are backed by scientific performance data and include CB4 Relief and CB4 Relief-T oral CBD Softgel capsules formulated with VESIsorb® technology, as well as topical CB4 Relief Deep Rub Gel formulated with enhanced skin permeation technology for maximum absorption through the skin. About Heritage Cannabis Holdings Corp.

Recreational 98

Recreational Vaping Concentrates Clinical Trials 98

Cannabis Law Report

SEPTEMBER 20, 2021

The products leverage pharmaceutical technology to maximize performance and safety. Additional CB4 products from the Opticann suite of branded products will be launched in the upcoming weeks, including CB4 Derma skin cream and CB4 Clear face gel skincare products uniquely backed by product specific clinical trial data.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

Cannabis Law Report

JANUARY 10, 2022

In addition, rising strategic initiatives by key players in the form of collaborations, clinical trials, and production are further contributing to increasing awareness and adoption of THCV products. For instance, as of June 2021, InMed Pharmaceuticals, Inc., Key Topics Covered: Chapter 1 Methodology and Scope.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Project CBD

MAY 3, 2023

It’s noteworthy that much of this anecdotal data is supported by findings from preclinical research. I’ve seen it as flower, I’ve seen it as topical, which has anti-bacterial and anti-psoriatic effects. Remember, the pharmaceutical model is “this medicine addresses this specific target.”

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. listed common and severe side effects.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

OCTOBER 6, 2021

With the additional funding recently secured by Virpax and the strengthening of our balance sheet, we are continuing to advance our product candidates and to move them through preclinical studies and into human clinical trials,” said Anthony Mack, Chairman and Chief Executive Officer of Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

Cannabis Law Report

AUGUST 17, 2021

Technology licensing should be on the radar for pharmaceutical companies offering drugs for respiratory diseases. Key Topics Covered: 1.0 Most of the Mobile Medical Applications in Clinical Trials are Monitoring Symptoms that can Support Early Disease Diagnosis. Strategic Imperatives. The Strategic Imperative. Clin-e-cal.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Types of Research.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

For example, many anti-anxiety pharmaceuticals are habit-forming, entail significant negative side effects, and can also cause physical problems such as diminished mobility or coordination. CBD is also available in conventional pill and tablet form, as a base to use for cooking, and in topical products. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

OCTOBER 1, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Additionally, a video webcast of the presentation will be available beginning October 7, 2021 on the Investors section of the Virpax Pharmaceuticals website at [link]. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS About Channelchek.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 10, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Once the Envelta IND-enabling studies are submitted to the FDA, the data may be cross-referenced to our cancer pain and PTSD INDs. About Virpax Pharmaceuticals. Virpax is initially seeking FDA approval of its three patented drug delivery platforms.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

MARCH 29, 2020

When companies, individuals or groups conduct or commission research of any kind on cannabis product one or more of its various forms (edibles, topicals, beverages, etc.) triggering new innovations and improved data quality through better user experiences. Setting Standards for Cannabis Research Studies .

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. How classical pharmaceuticals fight HIV. But I haven’t seen any clinical trials looking at the direct effects of THC on the virus.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Puff Puff Post

SEPTEMBER 16, 2019

Clinical toolkits to help navigate patient assessment and follow-ups. “A significant issue preventing the consideration of cannabinoid medicine by healthcare professionals is that the topic is not typically included in the medical school curriculum,” comments Dr. Mark Ware, Chief Medical Officer, Canopy Growth.

Programs 108

Programs Research and Development Education Treatment 108

Cannabis Law Report

DECEMBER 2, 2021

Below is a breakdown of the topics core training covers and the minimum hours students would devote to each subject: Historical, Traditional, and Contemporary Plant Medicine Practices and Applications (12 Hours). Programs shall train students in the fiduciary duties that facilitators owe clients and the consequences of breaching those duties.

Law 52

Law Programs Therapy Education 52

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. I don’t know if we’ll have topicals initially, or later on. Though hopefully this will not be the case for much longer.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Harris has written a variety of books that touch on the topics of consciousness, spirituality, and psychedelics. Rick Doblin, Ph.D,

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

CannaMD

OCTOBER 7, 2019

In 2011, researchers published cross-sectional data from two population-based surveys including over 50,000 respondents. Researchers also point out: For many patients, cannabis may be a better option for weight loss than surgery or pharmaceuticals. Believe it or not, science says: YES. Take the American Journal of Epidemiology.

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

Cannabis Law Report

JULY 24, 2019

March 25, 2019 posting – “CBD is being adopted more and more as a natural alternative to pharmaceutical-grade treatments for depression and anxiety.”. FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective. 331(d) and 355(a).

CBD 51

CBD Tincture Pets Chronic Pain 51

Puff Puff Post

SEPTEMBER 16, 2019

Clinical toolkits to help navigate patient assessment and follow-ups. “A significant issue preventing the consideration of cannabinoid medicine by healthcare professionals is that the topic is not typically included in the medical school curriculum,” comments Dr. Mark Ware, Chief Medical Officer, Canopy Growth.

Programs 40

Programs Research and Development Education Treatment 40

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Data collection. One coder then independently coded the entire dataset and entered the data into NVivo v12.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 17, 2019

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018.

Law 40

Law Seed-To-Sale Hemp Recreational 40